drugset / Trial / NCT00000224

Alternate-Day Buprenorphine. Phase V - 6

NCT00000224

CrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate buprenorphine blockade challenge.

Timeline

Start
1993-02
Primary completion
Completion

Publications

  • Background Bickel, Amass, Badger (in preparation) A double-blind controlled trial of buprenorphine dosing every 72 hours in opioid dependenct humans. Bickel, Amass, Badger (in preparation) A double-blind controlled trial of buprenorphine dosing every 72 hours in opioid dependent humans.

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified